Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H T Duc

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Advances in Experimental Medicine and Biology|February 23, 1999
Use of the IGF-I antisense strategy in the treatment of the hepatocarcinomaL C Upegui-Gonzalez, H T Duc, Y Buisson, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 31, 2006
Modulated expression of cell surface molecules and in vivo outgrowth of modified melanoma cellsS Trabado, P Nguyen Van Binh, C Martin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 3, 1999
Plasma membrane potential in thymocyte apoptosisB Dallaporta, P Marchetti, M A de Pablo, et al.
Neuroscience Letters|February 25, 2000
Expression of insulin-like growth factor-I in rat glioma cells is associated with change in both immunogenicity and apoptosisA Ly, C Bouchaud, D Henin, et al.
Archives of Toxicology|January 1, 1997
Implication of CYP 3A in the toxicity of cyclosporin G (CsG), cyclosporin A (CsA) and FK506 on rat hepatocytes in primary cultureS Ellouk-Achard, C Martin, C Pham-Huy, et al.
Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement|January 1, 1995
Analysis of (S)- and (R)-propranolol in human plasma and urine by a specific immunoenzymatic assay versus HPLCC Pham-Huy, A Sahui-Gnassi, F Massicot, et al.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1996
[Immunotherapy of tumors expressing IGF-I]J Trojan, H T Duc, C Lafarge-Frayssinet, et al.
Journal of Hepatology|December 2, 1998
Induction of apoptosis in rat hepatocarcinoma cells by expression of IGF-I antisense c-DNAS Ellouk-Achard, S Djenabi, G A De Oliveira, et al.
Molecular Pathology : MP|July 31, 2001
Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastomaA Ly, H T Duc, M Kalamarides, et al.
Hepato-Gastroenterology|July 21, 2001
IGF-I triple helix strategy in hepatoma treatmentL C Upegui-Gonzalez, A Ly, M Sierzega, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Advances in Experimental Medicine and Biology|February 23, 1999
Use of the IGF-I antisense strategy in the treatment of the hepatocarcinomaL C Upegui-Gonzalez, H T Duc, Y Buisson, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 31, 2006
Modulated expression of cell surface molecules and in vivo outgrowth of modified melanoma cellsS Trabado, P Nguyen Van Binh, C Martin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 3, 1999
Plasma membrane potential in thymocyte apoptosisB Dallaporta, P Marchetti, M A de Pablo, et al.
Neuroscience Letters|February 25, 2000
Expression of insulin-like growth factor-I in rat glioma cells is associated with change in both immunogenicity and apoptosisA Ly, C Bouchaud, D Henin, et al.
Archives of Toxicology|January 1, 1997
Implication of CYP 3A in the toxicity of cyclosporin G (CsG), cyclosporin A (CsA) and FK506 on rat hepatocytes in primary cultureS Ellouk-Achard, C Martin, C Pham-Huy, et al.
Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement|January 1, 1995
Analysis of (S)- and (R)-propranolol in human plasma and urine by a specific immunoenzymatic assay versus HPLCC Pham-Huy, A Sahui-Gnassi, F Massicot, et al.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1996
[Immunotherapy of tumors expressing IGF-I]J Trojan, H T Duc, C Lafarge-Frayssinet, et al.
Journal of Hepatology|December 2, 1998
Induction of apoptosis in rat hepatocarcinoma cells by expression of IGF-I antisense c-DNAS Ellouk-Achard, S Djenabi, G A De Oliveira, et al.
Molecular Pathology : MP|July 31, 2001
Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastomaA Ly, H T Duc, M Kalamarides, et al.
Hepato-Gastroenterology|July 21, 2001
IGF-I triple helix strategy in hepatoma treatmentL C Upegui-Gonzalez, A Ly, M Sierzega, et al.
Pageof 7